Results

GSK - GlaxoSmithKline plc

07/10/2019 | Press release | Distributed by Public on 07/10/2019 00:06

ViiV Healthcare announces phase III study meets primary endpoint, demonstrating the ability to control HIV-1 with a 2-drug regimen of dolutegravir plus lamivudine in virally[...]